DekaBank Deutsche Girozentrale Acquires 2,313 Shares of HCA Healthcare, Inc. $HCA

DekaBank Deutsche Girozentrale increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 98,819 shares of the company’s stock after purchasing an additional 2,313 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in HCA Healthcare were worth $37,318,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of HCA. Park Place Capital Corp grew its stake in HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after purchasing an additional 2,698 shares during the period. Harrell Investment Partners LLC boosted its stake in HCA Healthcare by 176.3% during the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after buying an additional 1,158 shares during the period. Brown Advisory Inc. raised its holdings in shares of HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after acquiring an additional 1,622 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of HCA Healthcare by 2.5% during the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock worth $1,491,000 after purchasing an additional 105 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have issued reports on HCA. Jefferies Financial Group lifted their target price on shares of HCA Healthcare from $400.00 to $485.00 in a research report on Wednesday, October 15th. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. The Goldman Sachs Group began coverage on HCA Healthcare in a research note on Tuesday, October 14th. They set a “buy” rating and a $470.00 price target for the company. Barclays raised their price objective on HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a report on Thursday, September 18th. Finally, Wells Fargo & Company increased their price target on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $437.19.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $431.62 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01. The stock’s 50 day simple moving average is $411.88 and its 200 day simple moving average is $379.69. The firm has a market cap of $101.00 billion, a price-to-earnings ratio of 18.14, a PEG ratio of 1.37 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.